Security key
74065P101
Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD)
CUSIP: 74065P101
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 65,427,364
- Total 13F shares
- 34,109,145
- Share change
- -1,039,320
- Total reported value
- $235,382,986
- Price per share
- $6.90
- Number of holders
- 64
- Value change
- -$10,995,652
- Number of buys
- 28
- Number of sells
- 43
Report period
Q1 2022
Institutions
64
Top holders
10
PRLD full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Prelude Therapeutics Inc SEC filings
Prelude Therapeutics Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74065P101
Recent filing periods:
Top shareholders of PRLD - Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
15%
|
10,123,824
|
$126,042,000 | — | 31 Dec 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
15%
|
10,039,691
|
$124,994,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
9.1%
|
5,938,933
|
$73,939,000 | — | 31 Dec 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
2.3%
|
1,513,686
|
$18,845,391 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.4%
|
896,504
|
$11,161,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
845,697
|
$10,528,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
771,440
|
$9,604,000 | — | 31 Dec 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.89%
|
583,333
|
$7,262,000 | — | 31 Dec 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.72%
|
468,797
|
$5,837,000 | — | 31 Dec 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.68%
|
444,111
|
$5,529,000 | — | 31 Dec 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.56%
|
368,959
|
$4,594,000 | — | 31 Dec 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.47%
|
304,332
|
$3,789,000 | — | 31 Dec 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.43%
|
282,774
|
$3,521,000 | — | 31 Dec 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.41%
|
268,018
|
$3,337,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
212,636
|
$2,647,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.32%
|
208,406
|
$2,595,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.21%
|
138,500
|
$1,725,000 | — | 31 Dec 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.2%
|
130,280
|
$1,622,000 | — | 31 Dec 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.19%
|
127,200
|
$1,584,000 | — | 31 Dec 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.18%
|
116,303
|
$1,448,000 | — | 31 Dec 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.17%
|
114,249
|
$1,422,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.17%
|
113,335
|
$1,411,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
107,184
|
$1,335,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
85,137
|
$1,060,000 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.13%
|
84,300
|
$1,050,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
78,481
|
$977,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
57,676
|
$718,000 | — | 31 Dec 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.07%
|
48,667
|
$606,000 | — | 31 Dec 2021 | |
| Pinz Capital Management, LP |
13F
|
Company |
0.07%
|
43,800
|
$545,000 | — | 31 Dec 2021 | |
| Walleye Capital LLC |
13F
|
Company |
0.06%
|
41,954
|
$522,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.06%
|
40,517
|
$504,000 | — | 31 Dec 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
39,014
|
$486,000 | — | 31 Dec 2021 | |
| Jump Financial, LLC |
13F
|
Company |
0.06%
|
36,900
|
$459,000 | — | 31 Dec 2021 | |
| PDT Partners, LLC |
13F
|
Company |
0.05%
|
35,907
|
$447,000 | — | 31 Dec 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
29,275
|
$364,000 | — | 31 Dec 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.04%
|
28,440
|
$354,000 | — | 31 Dec 2021 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
27,500
|
$342,000 | — | 31 Dec 2021 | |
| NORGES BANK |
13F
|
Company |
0.04%
|
25,000
|
$311,000 | — | 31 Dec 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
23,468
|
$292,000 | — | 31 Dec 2021 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.04%
|
23,384
|
$291,000 | — | 31 Dec 2021 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
22,832
|
$284,000 | — | 31 Dec 2021 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.03%
|
21,900
|
$273,000 | — | 31 Dec 2021 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.03%
|
21,393
|
$266,000 | — | 31 Dec 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.03%
|
20,773
|
$259,000 | — | 31 Dec 2021 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.03%
|
20,350
|
$253,000 | — | 31 Dec 2021 | |
| Trexquant Investment LP |
13F
|
Company |
0.03%
|
19,458
|
$242,000 | — | 31 Dec 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
16,470
|
$205,000 | — | 31 Dec 2021 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.02%
|
13,815
|
$172,000 | — | 31 Dec 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
13,300
|
$166,000 | — | 31 Dec 2021 | |
| Parkwood LLC |
13F
|
Company |
0.02%
|
12,667
|
$158,000 | — | 31 Dec 2021 |
Institutional Holders of Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) as of Q1 2022
As of 31 Mar 2022,
Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,109,145 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, FMR LLC, UBS ASSET MANAGEMENT AMERICAS INC, BlackRock Inc., VANGUARD GROUP INC, HHLR ADVISORS, LTD., MORGAN STANLEY, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and Rock Springs Capital Management LP.
This page lists
64
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
74
Q1 2022 holders
64
Holder diff
-10
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.